Skip to main content
. 2008 Mar 28;14(12):1891–1897. doi: 10.3748/wjg.14.1891

Table 5.

Risk assessment according to the KIT/PDGFRA mutations

Risk assessment
Benign (%) Very low malignant potential (%) Low malignant potential (%) Low moderate malignant potential (%) Malignant (%) P
KIT mutation
Positive 10.5 10.5 21.1 57.9 0.003
Negative 63.6 9.1 18.2 9.1
Exon 9 33.3 66.7 0.036
Exon 11 12.5 6.3 25 56.3
PDGFRA mutation
Positive NS
Negative 50 50